Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-23 Purchase | 2021-11-26 1:30 pm | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 20,000 | $2.4 | $48,000 | 3,180,465 (Indirect Direct) | View |
| 2021-08-16 Purchase | 2021-08-17 12:38 pm | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 152,857 | $0.32469 | $49,631 | 363,213 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 9:02 pm | N/A 2034-01-03 | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 9:28 pm | 2023-06-09 2032-06-09 | TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director | 5,000 | $0 | 12,495 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 6:58 pm | 2022-01-03 2032-01-02 | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 302,127 | $0 | 302,127 (Direct) | View |
| 2021-08-17 Conversion | 2021-08-17 12:38 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T President, CEO and Chairman 10% Owner | 38,866,391 | $0 | 363,213 (Indirect) | View |
Ownership | 2021-08-12 7:34 pm | N/A N/A | Dermata Therapeutics Inc. | DRMA | PROEHL GERALD T Pres., CEO and Chairman 10% Owner | 0 | $0 | 37,910,987 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-15 4:34 pm | 2022-06-10 2031-06-10 | TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2020-05-01 Option Award | 2020-05-15 5:01 pm | 2021-05-01 2030-05-01 | TENAX THERAPEUTICS INC. | TENX | PROEHL GERALD T Director | 500 | $0 | 500 (Direct) | View |
| 2019-06-27 Option Award | 2019-06-28 4:31 pm | 2019-07-27 2029-06-26 | SOPHIRIS BIO INC. | SPHS | PROEHL GERALD T Director | 20,000 | $0 | 20,000 (Direct) | View |